Global: Free-trade provisions will damage access to medicines

Impact studies warn that TRIPS-Plus provisions can lead to higher prices and reduced access to medicines, say Nusaraporn Kessomboon and colleagues in this article. The non-technical term TRIPS?Plus refers to provisions for the protection of intellectual property rights that go beyond the World Trade Organisation's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement). They include extending the life of a patent beyond the minimum requirement imposed by TRIPS; limiting government permission to reproduce a patented product or to reprocess without the patent owner's consent ('compulsory licensing') in ways not required by TRIPS; and limiting exceptions that facilitate the prompt introduction of generic drugs into the market.